Connection

Graham Warren to Antineoplastic Agents

Back to Details
This is a "connection" page, showing publications Graham Warren has written about Antineoplastic Agents.
Graham Warren
Connection Strength
0.816
Antineoplastic Agents
  1. Attributable Failure of First-line Cancer Treatment and Incremental Costs Associated With Smoking by Patients With Cancer. JAMA Netw Open. 2019 04 05; 2(4):e191703.
    View in: PubMed
    Score: 0.399
  2. Cigarette smoking and systemic therapy for lung cancer: considering the evidence to improve cancer care. J Thorac Oncol. 2014 Jul; 9(7):914-916.
    View in: PubMed
    Score: 0.287
  3. A phase II trial of erlotinib monotherapy in advanced pancreatic cancer as a first- or second-line agent. Cancer Chemother Pharmacol. 2017 Sep; 80(3):497-505.
    View in: PubMed
    Score: 0.088
  4. Cyclooxygenase-2 inhibitor, nimesulide, improves radiation treatment against non-small cell lung cancer both in vitro and in vivo. Oncol Rep. 2006 Oct; 16(4):771-6.
    View in: PubMed
    Score: 0.042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.